Search Results (1,675)

Background/Objectives: Copper is an essential trace element for physiological processes related to reproduction, but its impact on the hypothalamic–pituitary–ovarian (HPOA) axis and its specific mechanism remain unclear. Methods: In vivo study: 21-day-old female Sprague Dawley (SD) rats were randomly assigned to five groups (n = 10 per group), with all groups fed a basal diet and supplemented with CuSO₄·5H₂O to achieve copper ion concentrations of 0, 15, 30, 45, or 60 mg/kg in the diet. During the second phase of proestrus, blood samples, hypothalamic tissues, pituitary tissues, and ovarian tissues were collected. In vitro study: Primary mixed hypothalamic neurons were isolated and cultured from fetal SD rats on embryonic day 17. After identification by NSE immunofluorescence staining, six copper ion concentration groups (0, 15.6, 31.2, 46.8, 62.4, and 78 μmol/L) were established. The optimal copper concentration for cell viability and GnRH secretion was screened using CCK-8 assay (Sangon, Shanghai, China) and ELISA (Mlbio, Shanghai, China). On this basis, the cells were treated with different concentrations of PKC agonist (PMA) and PKC inhibitor (chelerythrine). Cell viability was evaluated by CCK-8 assay, the expression level of PKC was detected by Western blot, and the optimal concentration with no obvious toxicity was selected for subsequent mechanism research. Results: Dietary copper dose-dependently regulated rat puberty onset; the 45 mg/kg copper group had the earliest onset, and showed significantly increased levels of reproduction-related hormones (GnRH, FSH, LH, E₂) in serum and HPOA axis. Hypothalamic transcriptomics revealed significantly enriched GnRH signaling pathways and GABAergic synaptic pathways. Mechanistically, this copper dose upregulated hypothalamic KISS-1, GPR54, and PKC (mRNA/protein), and downregulated GABA/GABA-R. Adding 46.8 μmol/L copper (as Cu²⁺, equivalent to optimal in vivo level) could activate the KISS-1/GPR54-GnRH system in hypothalamic neurons; regulating PKC activity could synchronously affect the expression of KISS-1, GPR54, GnRH, and GABA/GABA-R, with additional copper enhancing this effect in vitro experiments. Conclusions: This study demonstrates for the first time that dietary copper at 45 mg/kg promotes puberty onset in SD rats. The mechanism involves activation of the hypothalamic PKC pathway, which inhibits GABAergic neurotransmission while activating the KISS-1/GPR54-GnRH system, thereby enhancing HPOA axis activity and gonadotropin secretion. Full article

Sleep disorders represent a growing global health concern with significant socio-economic impacts. GABA, a natural bioactive compound abundant in various fermented foods, especially probiotic-fermented foods, has garnered increasing attention for its potential to improve sleep quality. This review systematically elucidates the multi-pathway mechanisms by which GABA regulates sleep, focusing on (1) indirect modulation of central sleep–wake circuits via the gut–brain axis through vagal nerve, neuroendocrine, and immune pathways; (2) potential entry into the brain by leveraging the dynamic permeability of the blood–brain barrier (BBB) and transporter-mediated active transport; and (3) metabolic conversion into active substances like γ-hydroxybutyrate (GHB), which synergistically optimizes sleep architecture via multiple receptor systems and energy metabolism. Furthermore, we summarize the sleep-promoting effects of GABA-enriched foods observed in animal and clinical studies and discuss emerging applications, including high-GABA-yielding probiotics and personalized nutrition strategies for sleep intervention. This review provides a theoretical basis and innovative directions for the development of GABA-based functional foods and sleep health management. Full article

Growing market demand exists for strawberry, with nutrient-rich and health-promoting properties, beyond mere taste and flavor. Genetic biofortification is a powerful strategy to enhance nutrient metabolites in strawberry. Both GABA and organic acids contribute to human health by supporting nervous system relaxation and enhancing metabolic and digestive functions, respectively. However, the regulatory mechanisms underlying their accumulation remain poorly understood. In this study, we analyzed the accumulation patterns of GABA and organic acids across four fruit developmental stages in two representative cultivars, ‘Monterey’ and ‘Benihoppe’. Ripening ‘Benihoppe’ fruits accumulated higher levels of GABA and citric acid, whereas ‘Monterey’ fruits contained more malic acid. Integrated transcriptome analysis identified key structural genes and transcription factors (TFs) involved in GABA biosynthesis. Notably, functional characterization revealed that FaGAD4 significantly promotes GABA accumulation and simultaneously enhances the content of anthocyanin and ascorbic acid (AsA). Overall, this study provides novel insights into the regulatory mechanisms of GABA accumulation in strawberry fruit and identifies FaGAD4 and potential TFs as valuable genetic targets for molecular breeding. Full article

Pain remains a major clinical challenge due to its complex physiopathology and limited treatment options. In this context, several supplements based on palmitoylethanolamide (PEA) and alpha-lipoic acid (ALA) are known for their neuroprotective properties. ALA-based supplements have shown potential, but concerns about adverse effects persist. This study examines the formulations of two commercial products based on ALA and PEA, IperALA^® and IperALA^® Forte, in which ALA and vitamin D3 are replaced with Coriandrum sativum extract (C. sativum e.s.), N-acetylcysteine (NAC) and glutathione (GSH), assessing improvement of neuroprotective, anti-inflammatory and analgesic properties of the new formulation. Intestinal, blood–brain barrier (BBB), and central nervous system (CNS) models were sequentially stimulated with the test compounds. Both formulations were assessed for cytotoxicity, barrier integrity, permeability, oxidative stress, inflammation, and neuroprotection-related biomarkers. IperALA^® Forte demonstrated superior performance compared to IperALA^® and individual agents. It enhanced cell viability, preserved intestinal and BBB integrity, and improved compound permeability. Notably, it reduced ROS and pro-inflammatory cytokines (TNFα, IL-1), while increasing analgesic markers (CB2R, GABA) in the central system. The replacement of ALA and vitamin D3 with C. sativum, NAC, and GSH in IperALA^® Forte significantly improved the neuroprotective, antioxidant, and anti-inflammatory profile of the supplement. These results indicate a possible connection between the observed neuroprotective properties and the pathways involved in nociception and pain regulation, stating the hypothetical potential relevance of this approach for the treatment of pain-related conditions. Full article

Localized ¹H magnetic resonance spectroscopy (MRS) is a powerful tool in pre-clinical and clinical neurological research, offering non-invasive insight into neurochemical composition in localized brain regions. Zebrafish (Danio rerio) are increasingly being utilized as models in neurological disorder research, providing valuable insights into disease mechanisms. However, the small size of the zebrafish brain and limited MRS sensitivity at low magnetic fields hinder comprehensive neurochemical analysis of localized brain regions. Here, we investigate the potential of ultra-high-field (UHF) MR systems, particularly 28.2 T, for this purpose. This present study pioneers the application of localized ¹H spectroscopy in zebrafish brain at 28.2 T. Point resolved spectroscopy (PRESS) sequence parameters were optimized to reduce the impact of chemical shift displacement error and to enable molecular level information from distinct brain regions. Optimized parameters included gradient strength, excitation frequency, echo time, and voxel volume specifically targeting the 0–4.5 ppm chemical shift regions. Exceptionally high-resolution cerebral metabolite spectra were successfully acquired from localized regions of the zebrafish brain in voxels as small as 125 nL, allowing for the identification and quantification of major brain metabolites with remarkable spectral clarity, including lactate, myo-inositol, creatine, alanine, glutamate, glutamine, choline (phosphocholine + glycerol-phospho-choline), taurine, aspartate, N-acetylaspartyl-glutamate (NAAG), N-acetylaspartate (NAA), and γ-aminobutyric acid (GABA). The unprecedented spatial resolution achieved in a small model organism enabled detailed comparisons of the neurochemical composition across distinct zebrafish brain regions, including the forebrain, midbrain, and hindbrain. This level of precision opens exciting new opportunities to investigate how specific diseases in zebrafish models influence the neurochemical composition of specific brain areas. Full article

Parkinson’s disease (PD) is a multisystem disorder, with early changes extending beyond basal ganglia circuitries and involving non-dopaminergic pathways, including cerebellar networks. Whether cerebellar dysfunction reflects a compensatory mechanism or an intrinsic hallmark of disease progression remains unresolved. In this cross-sectional study, we examined how cerebellar γ-aminobutyric acid (GABA) and glutamate/glutamine (Glx) systems, as well as their excitatory/inhibitory (E/I) balance, are modulated along the disease course. As to ascertain how these mechanisms contribute to motor and non-motor features in the premotor and early stages of PD, 18 individuals with isolated REM sleep behavior disorder (iRBD), 20 de novo, drug-naïve PD (dnPD), and 18 matched healthy controls underwent clinical, cognitive, and neuropsychiatric assessments alongside cerebellar magnetic resonance spectroscopy (MRS, MEGA-PRESS, 3T). While cerebellar neurotransmitter levels did not differ significantly across groups, dnPD patients exhibited a shift toward hyperexcitability in the E/I ratio, without correlation to clinical or cognitive measures. In contrast, in iRBD, an inverse relationship between heightened GABAergic activity and neuropsychiatric symptoms emerged. These findings suggest an early, dynamic cerebellar involvement, potentially reflecting compensatory modulation of altered basal ganglia output. Our results support cerebellar GABA MRS as a promising biomarker and open perspectives for targeting non-dopaminergic pathways in PD. Full article

Background/Objectives: This study reports pilot-scale production of gluten-free rice malt extract powder from Thai Chainat 1 rice as a sustainable alternative to barley malt extract. Methods: The process combined controlled malting with sequential enzymatic hydrolysis, optimized through bench-scale validation and scaled up to a 1500 L pilot system. Results: The resulting powder was rich in fermentable sugars (maltose 43.9 g/100 g, glucose 14.3 g/100 g), protein (5.2 g/100 g), γ-aminobutyric acid (GABA, 245.2 mg/100 g), and thiamine (0.64 mg/100 g), while free of detectable gluten, aflatoxins, and heavy metals. Microbiological quality met international safety standards. Shelf-life studies under ambient and accelerated conditions demonstrated chemical stability and bioactive retention for up to three years in laminated and HDPE packaging. Application trials confirmed that the rice malt extract powder supported yeast, bacterial, and mold growth comparably to commercial malt extract in culture media, with optimized yeast–mold agar formulations enabling direct substitution without supplementary glucose. The powder was further applied to a gluten-free malt beverage, yielding a beer-like product with acceptable physicochemical and nutritional quality, though residual alcohol levels exceeded the non-alcoholic threshold and required process optimization. Conclusions: Rice malt extract powder represents a safe, functional ingredient suitable for food, beverage, and industrial microbiology applications, offering opportunities to reduce import dependency and advance gluten-free innovation in emerging markets. Full article

Treatment-resistant depression (TRD) affects 20–30% of patients with major depressive disorder and presents a significant clinical challenge due to its biological diversity. This review highlights standard mechanisms that contribute to treatment resistance beyond traditional monoaminergic models. Evidence supports serotonergic dysregulation, including 5-HT1A autoreceptor dysfunction and “serotonin flooding” as well as dopaminergic deficits linked to anhedonia and an imbalance between glutamate and GABA that impair synaptic plasticity. Changes in neurotrophic signaling, such as reduced BDNF and VEGF activity, complicate recovery by limiting neural repair and regeneration. Chronic inflammation and oxidative stress contribute to neuronal dysfunction, while HPA axis dysregulation may exacerbate depressive symptoms and resistance to antidepressants. Emerging evidence suggests that obesity and gut microbiota imbalance reduce the production of short-chain fatty acids by bacteria and increase intestinal permeability, thereby influencing neuroinflammatory and neurochemical processes in TRD. Neuroimaging studies reveal hyperconnectivity within the default mode network and impaired reward circuits, both of which are associated with persistent symptoms and a poor treatment response. By combining evidence on inflammation, oxidative stress, neuroendocrine disturbances, microbiome changes, and brain connectivity issues, this review develops a comprehensive framework for understanding TRD. It emphasizes the importance of biomarker-based subtyping to guide personalized future treatments. Full article

6-Prenylnaringenin (6-PN) is a natural compound which occurs in some plants, but the primary dietary source for humans is beer. This compound exhibits broad and potent antimicrobial, anticancer, and neuroactive properties, and weak estrogenic effects. Currently, hop extracts standardized for 6-PN content (relative to other prenylflavonoids) are commercially available and utilized in the non-hormonal treatment of menopause. It is probable that in the future, 6-PN will be employed in the prevention or treatment of non-hormone-dependent cancers and infectious diseases, as well as a sedative, hypnotic, and analgesic agent. Further research is essential to precisely determine the exact mechanisms of action of 6-PN and, critically, to leverage its unique therapeutic profile. This review synthesizes current evidence, highlighting that 6-PN warrants priority investigation as a core scaffold for novel drug development, particularly as a GABA_A positive allosteric modulator and a synergistic antimicrobial agent, potentially offering a safer alternative to more potent phytoestrogens found in hops. Full article

Background/Objectives: γ-aminobutyric acid (GABA), a non-protein amino, is synthesized from glutamic acid through the catalytic activity of glutamate decarboxylase (GAD). As a key signaling molecule, GABA plays a vital role in plant responses to abiotic stresses. To explore the potential involvement of the GABA gene family in Juglans regia’s response to environmental stressors, a comprehensive genome-wide identification and analysis of GABA-related genes was performed. Methods: The study examined their protein features, evolutionary relationships, chromosomal locations, and promoter cis-regulatory elements. Additionally, the expression patterns of GABA family genes were analyzed in J. regia seedlings subjected to salt and drought stress. Results: Genome analysis identified three main components of the GABA metabolic pathway in J. regia: glutamate decarboxylases (GADs), GABA transaminases (GABA-Ts), and succinic semialdehyde dehydrogenases (SSADHs). These genes were unevenly distributed across 14 chromosomes, with chromosome 10 containing the highest number. Promoter analysis revealed that about 80% of cis-acting elements were linked to plant hormone regulation, such as abscisic acid (ABA), and stress responses, including drought and high-salinity. Phylogenetic analysis showed that JrGAD1 was distantly related to other JrGAD members, while certain JrGABA-T and JrSSADH genes formed closely related pairs. Under salt and drought stress, JrSSADH23 expression was highly upregulated (2.60-fold and 2.24-fold, respectively), a trend observed for most JrSSADH genes. Conclusions: These findings offer valuable insights into the molecular basis of GABA metabolism in J. regia’s stress adaptation and identify promising genetic targets for developing stress-tolerant varieties. Full article

The current pharmacological approach for the treatment of opioid use disorder (OUD), as a result of prescription misuse or illicit opioids, utilises opioid ligands that have either an agonist or antagonist profile. In this context, methadone and buprenorphine act as opioid agonists, whereas naltrexone functions as an opioid antagonist. To decrease the reinforcing effects of illicit opioids, higher doses of methadone and buprenorphine have been recommended, but this is associated with increased side effects. Therefore, several preclinical efforts have been carried out over the last decades to find drugs that act on receptors other than opioid receptors. A large body of preclinical evidence has shown the ability of N-methyl-D-aspartate receptor (NMDAR) antagonists like ketamine to treat opioid addiction behaviours in animals. Indeed, ketamine by itself is an addictive drug; thus, the treatment of OUD is still a matter to be solved. Growing data position glycine transporter 1 as a possible therapeutic target for the treatment of substance use disorder. This transporter regulates the reuptake of glycine, which can modulate the function of both NMDARs and GPR158, a metabotropic glycine receptor (mGlyR); thus, it is worth investigating in the management of OUD. To gain insight into the role of glycinergic transmission in OUD, alongside NMDAR-mediated glutamatergic transmission, dopaminergic and GABAergic transmission were also reviewed. Full article

N-chlorotaurine (Tau-Cl) is a mild oxidizing haloamine formed from the reaction of hypochlorous acid (HOCl) with taurine (2-amino-ethanesulfonic acid). It is widely used as a topical antiseptic. In this study, we investigated haloamines derived from the neurotransmitter γ-aminobutyric acid, specifically GABA chloramine and bromamine (GABA-Cl, GABA-Br), as well as their halogenated γ-aminobutyric acid ethyl esters (GABAet-Cl, GABAet-Br). Due to their higher hydrophobicity, the esterified haloamines were more potent oxidants in the presence of lyophilic surfactant micelles, demonstrating their greater ability to access hydrophobic environments. By using fluorescent azapentalenes as molecular targets incorporated into sodium dodecyl sulfate (SDS) micelles, the second-order oxidation rate constants (k₂) resulted in 1.15 × 10² and 1.10 × 10⁴ M⁻¹min⁻¹ for GABA-Cl and GABAet-Cl, respectively. As expected, due to the presence of a bromine atom, GABAet-Br was even more reactive (4.50 × 10⁶ M⁻¹min⁻¹). The ability of GABAet-Br to access hydrophobic sites was demonstrated by comparing the reaction rate using micelles generated by different surfactants such as SDS (4.5 × 10⁶ M⁻¹min⁻¹), cetyltrimethylammonium chloride (CTAC, 2.5 × 10⁴ M⁻¹min⁻¹), and triton X-100 (TX-100, 3.9 × 10³ M⁻¹min⁻¹). GABAet-Cl and GABAet-Br exhibited higher bactericidal activity against Staphylococcus aureus and Escherichia coli, probably due to their increased lipophilicity and improved penetration into microorganisms compared to GABA-Cl and GABA-Br. The enhancement of the oxidation capacity by GABAet-Cl and GABAet-Br represents a new direction in the exploration and application of haloamines as antiseptic agents. Full article

Korean melon (K-melon, Cucumis melo L. var. makuwa) is a key horticultural crop in the Republic of Korea, but its short shelf life restricts long-distance export. This study evaluated the modified atmosphere (MA) films of varying oxygen transmission rates (OTR) at controlled atmosphere (CA) storage under real maritime export conditions to Vietnam. In the non-permeable OTR 0 (Control) treatment, internal O₂ rapidly declined below the anaerobic compensation point (1.67% at 10d and 0.47% at 10+3d) while CO₂ accumulated to 32–36%. This ultra-low oxygen environment induced anaerobic metabolism, evidenced by strong accumulation of fermentative metabolites such as lactic acid, acetoin, and 2,3-butanediol, along with glucose/fructose retention and increases in alanine and γ-Aminobutanoic acid (GABA). These changes disrupted glycolysis and the Tricarboxylic acid cycle (TCA), consistent with CA shock, and were accompanied by rind blackening, elevated weight loss, and hue angle shifts toward yellow-orange. By contrast, OTR 10,000 and OTR 30,000 films significantly suppressed weight loss and color changes. Partial least squares-discriminant analysis (PLS-DA) identified volatile organic compounds, namely acetoin, 2,3-butanediol, and hexanal, as key discriminant metabolites, with OTR 30,000 clearly separated from other treatments at 10+3d, indicating minimal fermentation and oxidative stress. Microbial assays revealed a dose-dependent reduction in bacterial counts with increasing OTR, while fungal growth was most strongly suppressed under OTR 10,000. Overall, OTR 30,000 maintained the lowest and most stable levels of stress-related metabolites, minimized microbial proliferation, and preserved metabolic stability throughout shipping. This study provides the first quantitative evidence of anaerobic metabolic transition and primary metabolite accumulation in K-melons under actual export trials. The findings demonstrate that optimizing MA film permeability, particularly OTR 30,000 films, offers a practical and cost-efficient strategy to extend shelf life, maintain quality stability, and enhance the global export potential of K-melons. Full article

Background/Objectives: The gut microbiome is increasingly recognized as a key modulator of central nervous system function through the gut–brain axis. Dysbiosis has been associated with neuropsychiatric disorders such as depression, anxiety, impulsivity, cognitive decline, and addiction. This review aims to synthesize mechanistic insights and therapeutic perspectives on how gut microbiota influence mood regulation, decision-making, and cognitive processes. Methods: A comprehensive narrative review was conducted using peer-reviewed articles retrieved from PubMed, Scopus, and Web of Science up to August 2025. Studies were included if they explored microbiota-related effects on behavior, mood, cognition, or decision-making using human or animal models. Emphasis was placed on molecular mechanisms, microbiome-targeted therapies, and multi-omics approaches. Results: Evidence indicates that gut microbiota modulate neurochemical pathways involving serotonin, dopamine, GABA, and glutamate, as well as immune and endocrine axes. Microbial imbalance contributes to low-grade systemic inflammation, impaired neuroplasticity, and altered stress responses, all of which are linked to mood and cognitive disturbances. Specific microbial taxa, dietary patterns, and interventions such as probiotics, prebiotics, psychobiotics, and fecal microbiota transplantation (FMT) have shown promise in modulating these outcomes. The review highlights methodological advances including germ-free models, metagenomic profiling, and neuroimaging studies that clarify causal pathways. Conclusions: Gut microbiota play a foundational role in shaping emotional and cognitive functions through complex neuroimmune and neuroendocrine mechanisms. Microbiome-based interventions represent a promising frontier in neuropsychiatric care, although further translational research is needed to define optimal therapeutic strategies and address individual variability. Full article

Background: The water-soluble Grifola frondosa polysaccharides (GFPs) are the primary bioactive component of the edible and medicinal fungus Grifola frondosa. However, the digestive behavior of GFPs in the human gastrointestinal (GI) tract and their subsequent interaction with gut microbiota (GM) to exert health effects remain unclear. Methods: In this study, GFPs were extracted based on a traditional hot water decoction. An in vitro simulated GI digestion model and a human fecal microbiota fermentation model were established to systematically investigate the digestive stability of GFPs, GM modulation, and metabolite changes. Results: Results showed that GFPs remained structurally stable during in vitro oral, gastric, and small intestinal digestion, allowing them to reach the colon intact for microbial fermentation. During colonic fermentation, GFPs were efficiently degraded by GM, and significantly increased the relative abundance of beneficial bacteria such as Akkermansia, Bacteroides, Parabacteroides, and Lactobacillus while reducing the abundance of pathogenic Escherichia-Shigella. Meanwhile, GFPs enriched metabolites beneficial for intestinal health, among which γ-aminobutyric acid (GABA) was the most significantly upregulated. Single-strain fermentation confirmed that Lactobacillus (L. plantarum) was the core GABA-producing genus. Conclusions: This study highlights the potential of GFPs as prebiotics for GM modulation, expands the understanding of the health-promoting effects of fungal polysaccharides, and provides a theoretical basis for the development of GFP-based functional foods. Full article